跳至主要内容
临床试验/EUCTR2009-016855-23-GB
EUCTR2009-016855-23-GB进行中(未招募)1 期

Targeting systemic inflammation to improve endothelial function in obesity - Inflammation, obesity and endothelial function

niversity of Leeds0 个研究点目标入组 50 人开始时间: 2010年7月19日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • obesity (Body Mass Index 30 or greater)
  • not taking other medication (apart from oral contraceptives)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • hypertension
  • hyperlipidaemia
  • cardiovascular disease or history of cardiac arrythmias
  • chronic inflammatory disorders (e.g. rheumatoid arthritis, connective tissue disorders, gout, inflammatory bowel disease, chronic infections)
  • acute inflammatory illnesses (e.g. upper respiratory tract infections)
  • allergy to pentoxifylline or other methyl xanthine drugs or concomitant use of sildenafil, tadalafil, vardenafil or other phosphodiesterase 5 inhibitors
  • history of cerebral haemorrhage or retinal haemorrhage
  • pregnancy or breastfeeding
  • Impaired renal function
  • Hypotension (systolic blood pressure less than 90mmHg)

研究者

发起方
niversity of Leeds

相似试验